Clinical Trials

Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma

Study ID
Hoosier CRN GU16-260

NCT Number
NCT03117309 (Click on the NCT number for more information about the trial)

Research Study Number

Principle Investigator
Dr. Robert Alter


Hoosier Cancer Research Network

Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at

Apply Now